Select balance sheet data - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Select balance sheet data | |||||
| Depreciation expense | $ 8,094 | $ 7,870 | $ 15,913 | $ 15,619 | |
| Impairment of long-lived asset | 375 | ||||
| Assets reclassified to assets held-for-sale | 1,680 | 1,680 | |||
| Assets held for sale | $ 3,082 | $ 3,082 | $ 1,402 | ||
| X | ||||||||||
- Definition Amount of assets reclassified to assets held-for-sale that are not part of a disposal group during the period. No definition available.
|
| X | ||||||||||
- Definition Select balance sheet data. No definition available.
|
| X | ||||||||||
- Definition Amount of assets held-for-sale that are not part of a disposal group. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|